Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study.
Izu A, Mutsaerts EA, Olwagen C, Jose L, Koen A, Nana AJ, Cutland CL, Madhi SA. Izu A, et al. Expert Rev Vaccines. 2025 Dec;24(1):121-127. doi: 10.1080/14760584.2025.2458179. Epub 2025 Jan 27. Expert Rev Vaccines. 2025. PMID: 39865559 Free article. Clinical Trial.
Impact of Respiratory Syncytial Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection on Clinical Severity and Outcomes Among Children Hospitalized With Lower Respiratory Tract Infections in Soweto, South Africa.
Mrubata KL, Bailie V, Solomon F, Izu A, Ncube M, Nunes MC, Dangor Z, Madhi SA, Moore DP, Verwey C. Mrubata KL, et al. Among authors: izu a. Pediatr Infect Dis J. 2025 Feb 1;44(2):107-111. doi: 10.1097/INF.0000000000004560. Epub 2024 Oct 2. Pediatr Infect Dis J. 2025. PMID: 39733274 Free PMC article.
Single priming and a booster dose of 10-valent and 13-valent pneumococcal conjugate vaccine (PCV) maintains suppression of vaccine serotype colonization in South African children at 3, 4, and 5 years of age: a single-centre, open-labelled, randomized trial.
Olwagen CP, Izu A, Van der Merwe L, Jose L, Koen A, Madhi SA. Olwagen CP, et al. Among authors: izu a. Expert Rev Vaccines. 2024 Jan-Dec;23(1):1011-1019. doi: 10.1080/14760584.2024.2417856. Epub 2024 Oct 22. Expert Rev Vaccines. 2024. PMID: 39417218 Free article. Clinical Trial.
146 results